The novel HLA‐B*38:103N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual
HLA · 2024
DOI: 10.1111/tan.15405 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Shuang-Yue Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: HLA-B Antigens, Nucleotides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*38:103N differs from HLA‐B*38:02:01:01 by one nucleotide in exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
- Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
ORCID-Profile: Lin An
Zitieren
APA
Li, S. Y., An, L., Ding, P. P., Hu, X. Z., & Lu, Y. (2024). The novel HLA‐B*38:103N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. https://doi.org/10.1111/tan.15405
Vancouver
Li SY, An L, Ding PP, Hu XZ, Lu Y. The novel HLA‐B*38:103N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual. HLA. 2024. doi:10.1111/tan.15405
BibTeX
@article{Li2024,
author = {Li, Shuang-Yue and An, Lin and Ding, Pei-Pei and Hu, Xiao-Zhuang and Lu, Ying},
title = {The novel HLA‐B*38:103N allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15405}
}
EUVIMED